Tactile Systems Technology (TCMD) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $0.33
- Estimate
- $0.34
- Surprise
- -1.7%
- Revenue (period 2026-09-30)
- $91.9M
- Score at report (before → after)
- 6.4 → 6.3/10
Revenue source: xbrl.
How the report landed
Tactile Systems Technology (TCMD) missed the $0.34 estimate with adjusted EPS of $0.33 — a modest 1.7% shortfall. TrendMatrix's engine moved from Buy (Wait) (6.4/10) to Hold at 6.3/10 after the report.
Coverage in the report window
- BTIG Maintains Buy on Tactile Systems Tech, Lowers Price Target to $31 — benzinga, 2026-11-03
- Tactile Systems Tech Q3 2026 Earnings Call Transcript — benzinga, 2026-11-02
Where TrendMatrix's rating stands now
TrendMatrix currently rates TCMD Hold at 6.3/10.
2 of the last 4 quarters beat the estimate; this quarter's -1.7% surprise compares with a +55.1% four-quarter average.
What supports the rating
- Sector modifier (Healthcare): +0.5
- Attractive valuation
What argues against it
- Concentration risk — Product: lymphedema products (84.0%)
- Concentration risk — Supplier: single-source component suppliers
- Below 200-MA, MA slope -3.5%/30d (confirmed downtrend)
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $22.87
- Price target
- $32.02
- Stop
- $21.41
- Upside to target
- +40.0%
- Reward-to-risk
- 6.3:1
The stock trades at 21.0× trailing but 15.7× forward earnings — consensus estimates already build in a substantial earnings recovery.
Model outputs from TrendMatrix’s engine as of 2026-11-03 — shown for context, not personalized investment advice.
TCMD at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Medical Devices
- Market cap
- $518.1M
- P/E (fwd)
- 15.7
- P/E (ttm)
- 21.0
- 52-week range
- $15.32–$37.77
- Off 52-week high
- 39.4%
- RSI (14)
- 55
- Volume vs avg
- 1.33×
- Score today
- 6.3/10